KAM
EXAS

Knightsbridge Asset Management’s Exact Sciences EXAS Stock Holding History

Knightsbridge Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,105
Closed -$214K – 265
2025
Q4 		$214K Buy
+2,105
New +$169K 0.03% 209

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Knightsbridge Asset Management's EXAS Position: Q1 2026 in Review

Knightsbridge Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,105 shares — an estimated $214K sold.

Knightsbridge Asset Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $214K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Knightsbridge Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Knightsbridge Asset Management sold 2,105 Exact Sciences shares in Q1 2026, an estimated $214K.
  • Knightsbridge Asset Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Knightsbridge Asset Management's Exact Sciences position peaked at $214K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.